Investigating the Optimal Management of Dolutegravir Resistance
Recruiting
Observational Study
HIV-1-infection
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 1 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 6,600 (estimated)
- Sponsor
- University of Nairobi · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to address the gap in published data on viral suppression among people meeting the criteria for virologic failure on dolutegravir (DTG)-based ART regimens without a change in regimen. The study will also assess the emergence of DTG-associated drug-resistant mutations and their impact on viral suppression.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Able and willing to provide informed consent (assent as appropriate and legal guardian consent if \< 18 years)
* Age ≥ 1 years
* Documented HIV-1 infection as confirmed by national HIV testing standards at the respective study sites
* On a DTG-based ART regimen for at least si…
Contacts